Baird Financial Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
39,926
-11,255
| -22% | -$406K | ﹤0.01% | 1112 |
|
|
2025
Q1 | $1.59M | Sell |
51,181
-11,010
| -18% | -$343K | ﹤0.01% | 1032 |
|
|
2024
Q4 | $1.59M | Buy |
+62,191
| New | +$1.59M | ﹤0.01% | 1036 |
|
|
2022
Q4 | – | Sell |
-190,791
| Closed | -$7.67M | – | 1757 |
|
|
2022
Q3 | $7.67M | Sell |
190,791
-4,142
| -2% | -$166K | 0.02% | 467 |
|
|
2022
Q2 | $8.2M | Sell |
194,933
-4,500
| -2% | -$189K | 0.02% | 470 |
|
|
2022
Q1 | $7.77M | Sell |
199,433
-15,625
| -7% | -$609K | 0.02% | 503 |
|
|
2021
Q4 | $8.57M | Hold |
215,058
| – | – | 0.02% | 479 |
|
|
2021
Q3 | $7.77M | Buy |
+215,058
| New | +$7.77M | 0.02% | 482 |
|